Final 5-year IMCgp100-202 data show tebentafusp improved OS vs investigator’s choice in untreated HLA-A*02:01–positive metastatic uveal melanoma.
|Slideshows|February 27, 2015
Slide Show: Melanoma and Other Skin Cancers
Author(s)OncoTherapy Network Staff
This slide show features images of melanoma, basal cell carcinoma, squamous cell carcinoma, as well as images of metastatic disease.
Advertisement
Advertisement
Related to this article
The FDA approved the first and only photodynamic therapy for the treatment of a skin cancer.
Advertisement
Advertisement
Trending on CancerNetwork
1
Belzutifan Combo Receives FDA Approval in Advanced Clear Cell RCC
2
Daratumumab Combo Yields Responses in Cardiac-Involved AL Amyloidosis Trials
3
SOHO-02 Trial Will Confirm Sevabertinib’s Frontline NSCLC Benefit
4
Epcoritamab Combo Receives Canadian Approval in R/R Follicular Lymphoma
5